Each ml contains sodium hyaluronate 10 mg, sodium chloride 8.5 mg, disodium hydrogen phosphate dihydrate 0.28 mg, sodium dihydrogen phosphate hydrate 0.04 mg in sterile water for injection.

Indications: eye surgery. It maintains a deep anterior chamber during surgery, allowing for efficient manipulation with fewer traumas to the corneal endothelium and other surrounding tissues; its visco-elasticity helps to push back the vitreous fluid and prevent formation of a postoperative flat chamber. It is slowly removed after 6 days if left in the anterior segment of the eye after operation.

Cautions: increased intra-ocular pressure due to overfilling of the anterior or posterior segments of the eye.

Side Effects: post-operative inflammatory reactions, corneal oedema, corneal decompensation, transient post- operative rise in intra ocular pressure.

Dose: it varies with the type of surgery. Usually a dose of 0.2 to 0.6 ml is introduced through a thin cannula into the anterior segment of the eye during surgery, whereas larger amounts are used in the posterior segment.